Silicon Valley Capital Partners Viatris Inc Transaction History
Silicon Valley Capital Partners
- $767 Million
- Q3 2024
A detailed history of Silicon Valley Capital Partners transactions in Viatris Inc stock. As of the latest transaction made, Silicon Valley Capital Partners holds 1,362 shares of VTRS stock, worth $17,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,362
Previous 1,348
1.04%
Holding current value
$17,011
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
933MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.76 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$788 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$782 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$609 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...